Mutation screening for tyrosinaemia type I. [J Inherit Metab Dis. 2002]

Mutation analysis of the FAH gene in Israeli patients with tyrosinemia type I. [Hum Mutat. 2002]
Mutation analysis of the FAH gene in Israeli patients with tyrosinemia type I.
Elpeleg ON, Shaag A, Holme E, Zughayar G, Ronen S, Fisher D, Hurvitz H. Hum Mutat. 2002 Jan; 19(1):80-1.
Tyrosinaemia type I--de novo mutation in liver tissue suppressing an inborn splicing defect. [J Mol Med. 2005]
Tyrosinaemia type I--de novo mutation in liver tissue suppressing an inborn splicing defect.
Bliksrud YT, Brodtkorb E, Andresen PA, van den Berg IE, Kvittingen EA. J Mol Med. 2005 May; 83(5):406-10. Epub 2005 Mar 10.
Gene symbol: FAH. Disease: tyrosinaemia 1. [Hum Genet. 2005]
Gene symbol: FAH. Disease: tyrosinaemia 1.
Arranz A, Rigante D, Antuzzi D, Riudor E. Hum Genet. 2005 Dec; 118(3-4):537.
Review Hereditary tyrosinaemia type I: from basics to progress in treatment. [Ann Med. 2000]
Review Hereditary tyrosinaemia type I: from basics to progress in treatment.
Pitkänen ST, Salo MK, Heikinheimo M. Ann Med. 2000 Nov; 32(8):530-8.
Review Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1. [Mol Genet Metab. 2004]
Review Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1.
Balogh K, Patócs A, Majnik J, Rácz K, Hunyady L. Mol Genet Metab. 2004 Sep-Oct; 83(1-2):74-81.

A minor alternative transcript of the fumarylacetoacetate hydrolase gene produces a protein despite being likely subjected to nonsense-mediated mRNA decay. [BMC Mol Biol. 2005]
A minor alternative transcript of the fumarylacetoacetate hydrolase gene produces a protein despite being likely subjected to nonsense-mediated mRNA decay.
Dreumont N, Maresca A, Boisclair-Lachance JF, Bergeron A, Tanguay RM. BMC Mol Biol. 2005 Jan 7; 6(1):1. Epub 2005 Jan 7.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Mutation screening for tyrosinaemia type I.
Mutation screening for tyrosinaemia type I.
J Inherit Metab Dis. 2002 Oct ;25(6):523-4.

PubMed
[Favorable outcome of treatment with NTBC of acute liver insufficiency disclosin...
[Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I]
Arch Pediatr. 1999 May ;6(5):540-4.

PubMed
Orthotopic liver transplantation in children: two-year experience with 47 patien...
Orthotopic liver transplantation in children: two-year experience with 47 patients.
Pediatrics. 1984 Jul ;74(1):140-5.

PubMed
Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexa...
Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).
J Inherit Metab Dis. 1998 Aug ;21(5):507-17.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed